Joshua Fitch, Senior Editor

This decision marks the second time the FDA has issued a complete response letter (CRL) for dasiglucagon to treat hypoglycemia in patients 7 days and up with congenital hyperinsulinism.

Steven Selbst, MD, discusses a recent trend in emergency medicine where non-operative management of appendicitis is being considered as an alternative to traditional surgery.

While rates of exclusive breastfeeding have slightly increased between 2016 and 2022, they remain under the Healthy People 2030 goal.

Angela Chun, MEd, MD, FAAP, discusses common causes of pediatric joint pain, serious red flags, and the importance of timely diagnosis of conditions like JIA and silent uveitis.

This week, take a look at several video interviews with experts from the 2024 AAP meetings, all in one place.

At the 2024 AAP National Conference, Steven Selbst, MD, highlighted the rise in accidental THC ingestions among children, urging pediatricians to counsel parents on the dangers of improperly stored THC gummies that resemble candy.

Tanya Altmann, MD, discusses California's AB 899 law requiring baby food heavy metal testing, urging a balance between safety and maintaining nutrition quality.

Angela Chun, MEd, MD, FAAP, shares tips on distinguishing mechanical vs inflammatory joint pain in children, emphasizing timing, activity, and key physical exam maneuvers.

Rana Hamdy, MD, discussed her session at the 2024 AAP meeting, highlighting treatment duration with antibiotics for community-acquired pneumonia as well as the importance of understanding amoxicillin allergy.

John Loiselle, MD, FAAP, discusses pediatric musculoskeletal injuries, focusing on growth plates and age-specific anatomy at the 2024 AAP Conference.

Lori Byron, MD, emphasizes the harmful effects of extreme heat and wildfire smoke on children's health, urging education, sustainability, and collective action.

Tanya Altmann, MD, discusses the growing issue of childhood obesity in the United States and the benefits of new weight management medications.

A look into CDC numbers for increasing pertussis cases in the United States, along with commentary from our editor-in-chief, Tina Tan, MD, FAAP, FIDSA, FPIDS.

At AAP 2024, Rana Hamdy, MD, shared insights from her session, "Diagnosis and Treatment of Community-Acquired Pneumonia."

"It's unfortunate now that emergency departments need to prepare for disasters like that, and physicians everywhere need to prepare... They may need to come in."

“Children are most often coming across these drugs in familiar settings such as their home or the home of a relative,” said said Maria Quidgley-Martin, of research presented at the AAP National Conference & Exhibition.

“Getting outside and enjoying the fresh air can do wonders for your health while also upping Vitamin D absorption, said Jessica McQuerry, MD, lead study author of an abstract presented at the 2024 AAP National Conference & Exhibition.

“The significant rise in heat-related illnesses over the past decade underscores a growing public health concern that warrants further attention and action, said Taylor Merritt, MD, of the data presented at the AAP National Conference & Exhibition.

“Our study highlights the widespread nature of period poverty and the need for broad actions," said co-senior study author Meleah Boyle, PhD MPH at the 2024 AAP National Conference & Exhibition.

Infants were 22% less likely to develop asthma in early childhood if there were only fed breast milk during birth hospitalization, per a study presented at the 2024 AAP National Conference & Exhibition.

Our editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, previews some of the American Academy of Pediatrics National Conference & Exhibition, taking place right now in Orlando, Florida.

Eric Simpson, MD, MCR, FAAD, lead author of a recently-published article highlighting roflumilast cream 0.15%, joined us for a Q+A interview.

The needle-free option to treat type 1 allergic reactions, including anaphylaxis, was approved for adults and children who weigh 66 lbs or more on August 9, 2024.

With this acceptance, the federal agency has assigned a PDUFA date of May 22, 2025 for roflumilast foam (Zoryve) 0.3%.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to discuss potential advantages of LUM-201 as it goes through the clinical pipeline.

With this approval, FluMist becomes the first vaccine to prevent influenza that does not need to be administered by a health care provider.

The approval is indicated for adults and children aged 2 years and older, making arimoclomol (Miplyffa) the first drug approved by the FDA to treat NPC.

Those with inpatient food insecurity had an increased length of stay, as well as increased odds of readmission.

Infigratinib has also received Orphan Drug Designation, Fast Track Designation, and Rare Pediatric Disease Designation from the FDA.